Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2008-04-01
2008-04-01
Salimi, Ali R. (Department: 1648)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S345000, C435S006120
Reexamination Certificate
active
11302286
ABSTRACT:
A method for inducing a mucosal immunity with production of secretory IgA antibodies that neutralize of block a native E7 protein originating from cancerous cells, from cells infected by a human Papillomavirus or from an immune system cell. The method includes administering to a patient in need thereof, a vaccine composition containing an active compound which is the native E7 protein, the properties of which have been inactivated by at least 70% by a physical and/or a chemical treatment, by genetic recombination or by adjuvant conditions; an inactive fragment of the immunosuppressive and/or angiogenic native E7 protein; a DNA molecule encoding the immunosuppressive and/or angiogenic native E7 protein inactivated by at least 70% by mutation; or a DNA molecule encoding an inactive fragment of the immunosuppressive and/or angiogenic native E7 protein; along with an adjuvant of mucosal immunity.
REFERENCES:
patent: 6867033 (2005-03-01), Frazer et al.
patent: 7172870 (2007-02-01), Frazer et al.
patent: WO 96/27389 (1996-09-01), None
patent: WO 99/02712 (1999-01-01), None
patent: WO 99/39735 (1999-08-01), None
patent: WO 00/03732 (2000-01-01), None
Girard et al; “New Prospects for the Development of a Vaccine Against Human Immunodeficiency Virus Type 1,” Comptes Rendus de L'Academie des Sciences, Serie III, Sciences de la Vie, vol. 322, No. 11, Nov. 1999, pp. 959-966, France.
Boyaka et al, “Strategies for Mucosal Vaccine Development,” America Journal of Tropical Medicine and Hygiene, vol. 60, No. 4 Supplement, Apr. 1999, pp. 35-45.
Montgomery et al; “Induction of Secretory and Serum Antibody Responses Following Oral Administration of Antigen with Bioadhesive Degradable Starch Microparticles;” Oral Microbiology and Immunology, vol. 13, No. 3, Jun. 1998; pp. 139-149.
Boyaka et al; “HIV Tat Protein Regulation of Mucosal Immunity;” Journal of Human Virology, vol. 3, No. 5, Sep. 2000; pp. 10-15.
Murphy et al., Fields Virology, 2ndED., 1990, Chapter 19, pp. 480-482.
Ginkel et al., The Journal of Immunology, 2000, p. 4778-4782.
Zhang et al (Journal of Virology, Oct. 2004, vol. 78, No. 19, pp. 10249-10257.
Browdy and Neimark
Neovacs
Salimi Ali R.
LandOfFree
Use of inactive immunosuppressive and/or angiogenic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of inactive immunosuppressive and/or angiogenic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of inactive immunosuppressive and/or angiogenic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3933913